WMSA
PASG icon

Weiss Multi-Strategy Advisers’s Passage Bio PASG Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,145
Closed -$245K – 337
2023
Q4 		$245K Sell
12,145
-6,240
-34% -$86.1K 0.01% 504
2023
Q3 		$242K Hold
18,385
– – 0.01% 516
2023
Q2 		$346K Hold
18,385
– – 0.01% 590
2023
Q1 		$352K Hold
18,385
– – 0.01% 567
2022
Q4 		$507K Hold
18,385
– – 0.01% 511
2022
Q3 		$460K Buy
18,385
+2,963
+19% +$117K 0.01% 558
2022
Q2 		$728K Sell
15,422
-4,578
-23% -$214K 0.02% 514
2022
Q1 		$1.24M Buy
20,000
+948
+5% +$78.1K 0.03% 470
2021
Q4 		$2.42M Buy
19,052
+2,250
+13% +$367K 0.05% 362
2021
Q3 		$3.35M Sell
16,802
-183
-1% -$43.6K 0.07% 325
2021
Q2 		$4.5M Buy
16,985
+3,739
+28% +$1.16M 0.1% 282
2021
Q1 		$4.63M Sell
13,246
-1,782
-12% -$761K 0.1% 265
2020
Q4 		$7.68M Buy
15,028
+7,412
+97% +$2.97M 0.15% 190
2020
Q3 		$2M Buy
7,616
+386
+5% +$133K 0.05% 348
2020
Q2 		$3.95M Sell
7,230
-1,760
-20% -$791K 0.11% 238
2020
Q1 		$2.83M Buy
+8,990
New +$2.81M 0.11% 223

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PASG Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Passage Bio (PASG) in Q1 2024, closing a stake of 12,145 shares — an estimated $245K sold.

Weiss Multi-Strategy Advisers first reported a position in PASG in Q1 2020 and held it in 16 quarters. The position peaked at $7.68M in Q4 2020. 48 funds tracked by Wall St. Rank hold PASG as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Passage Bio position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,145 Passage Bio shares in Q1 2024, an estimated $245K.
  • Weiss Multi-Strategy Advisers first reported a position in Passage Bio in Q1 2020 and held it in 16 quarters.
  • Weiss Multi-Strategy Advisers's Passage Bio position peaked at $7.68M in Q4 2020.
  • 48 funds tracked by Wall St. Rank held Passage Bio as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.